whether angiotensin receptor blockers should be used to prevent nephropathy in type 2 diabetes

July 2001

Experts are debating whether angiotensin receptor blockers should be used to prevent nephropathy in type 2 diabetes.

ACE inhibitors are the drugs of choice to prevent diabetic nephropathy. Now there's growing evidence that angiotensin receptor blockers (ARBs) also slow the progression of renal disease.

So far Cozaar (losartan) and Avapro (irbesartan) are shown to help. The other ARBs probably give the same benefit.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote